Melioidosis presenting as sepsis syndrome: a case report

Int J Infect Dis. 2011 Mar;15(3):e217-8. doi: 10.1016/j.ijid.2010.11.009. Epub 2010 Dec 30.

Abstract

Melioidosis is an important disease in Asia and Australia. It is very rare in Venezuela. We describe the case of a 50-year-old diabetic patient with several episodes of right tibial osteomyelitis, left shoulder arthritis, sternal osteomyelitis, right parietal osteomyelitis, and subperiosteal abscess, followed by septic arthritis of the right knee. In all cases Gram stain smear showed Gram-negative bacilli. Culture yielded Burkholderia pseudomallei, susceptible to third- and fourth-generation cephalosporins, ciprofloxacin and aztreonam, and resistant to aminoglycosides. He developed sepsis syndrome. Blood cultures and culture of abscess and joint fluids also revealed B. pseudomallei. The patient was treated with ceftazidime and ciprofloxacin, then cefepime and trimethoprim-sulfamethoxazole. He was discharged with suppressive therapy consisting of oral doxycycline and trimethoprim-sulfamethoxazole, and follow-up has continued to date. At this time he remains asymptomatic. Melioidosis is an extremely rare disease in our country. To our knowledge, this is only the second case reported in Venezuela.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / diagnosis*
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Burkholderia pseudomallei / isolation & purification*
  • Cefepime
  • Ceftazidime / therapeutic use
  • Cephalosporins / therapeutic use
  • Ciprofloxacin / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Male
  • Melioidosis / diagnosis*
  • Melioidosis / drug therapy
  • Melioidosis / microbiology
  • Microbial Sensitivity Tests
  • Middle Aged
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Ciprofloxacin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Cefepime
  • Ceftazidime